Editors for Cancer Biology

We aim to publish conceptually important advances in all areas of cancer biology, including the discovery of new mechanisms responsible for cancer initiation, progression and therapy response. We are also interested in clinical trials or other clinical observations that reveal new and important biological insights. Read the latest research in this subject area.

Senior editors

  1. Eduardo Franco

    McGill University, Canada

    Eduardo Franco is Professor and Chairman, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University, Montreal. He holds BSc (1975) and Licentiate (1976) degrees in biology from Universidade de Campinas, Brazil, and master's (MPH) and doctoral (DrPH) degrees in public health microbiology from the University of North Carolina at Chapel Hill (1981-84). He was a Guest Researcher at the US Centers for Disease Control in Atlanta (1980-81 and 1983-84), and a post-doctoral fellow in cancer epidemiology during 1984 at the International Agency for Research on Cancer in Lyon, France, at the US National Cancer Institute (NCI) in Bethesda, and at Louisiana State University, in New Orleans. Since 1985, he has conducted epidemiologic research on the causes of cancer and on the means to prevent it or to improve patient survival. He is mostly known for his contributions to our understanding of human papillomavirus infection as the cause of cervical cancer and using this knowledge to prevent this cancer via vaccination and improved screening strategies. He received the Canadian Cancer Research Alliance’s Distinguished Service to Cancer Research Award, Lifetime Achievement Awards from the American Society for Colposcopy and Cervical Pathology and from the International Papillomavirus Society, the Women in US Government’s Leadership Award, the Canadian Cancer Society’s Warwick Prize, the Geoffrey Howe Outstanding Contribution Award from the Canadian Society for Epidemiology and Biostatistics, the University of British Columbia’s Chew Wei Memorial Prize in Cancer Research, and the McLaughlin-Gallie Award from the Royal College of Physicians of Canada. He has mentored 115 graduate students and post-doctoral fellows, and 30 undergraduate trainees. He is Officer of the Order of Canada and Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. Heholds an honorary doctorate from Universidade Fernando Pessoa, Porto, Portugal.

    Expertise
    Epidemiology and Global Health
    Cancer Biology
    Microbiology and Infectious Disease
    Research focus
    molecular epidemiology and prevention of cervical cancer and human papillomavirus-associated diseases
    cancers of the upper aero-digestive tract
    prostate, endometrium, and childhood tumours
    efficacy of cancer screening strategies
    the impact of measurement error in epidemiology
    societal and clinical influences on cancer patient survival
    Competing interests statement
    Entire research program funded by the Medical Research Council of Canada (until 1999), Canadian Institutes of Health Research (CIHR) (1999-present), National Institutes of Health, Canadian Cancer Society, and Cancer Research Society. He has received salary awards from the Fonds de Recherche Quebec Santé and CIHR. He holds a James McGill Professorship and the Minda de Gunzburg Endowed Chair at McGill University. He serves as Editor-in-Chief for Preventive Medicine and Preventive Medicine Reports and serves on the editorial boards of Cancer Epidemiology, Biomarkers & Prevention, International Journal of Cancer, Papillomavirus Research, and Salud Publica de Mexico. He has served as occasional consultant to companies involved with HPV vaccination (Merck and GSK) and HPV diagnostics (Roche, Abbott, Qiagen, and BD).
  2. Sean Morrison

    Sean Morrison

    Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, United States

    The Morrison laboratory studies the cellular and molecular mechanisms that regulate stem cell function in the nervous and hematopoietic systems. Dr Morrison obtained his BSc in biology and chemistry from Dalhousie University (1991), then completed a PhD in immunology at Stanford University (1996), and a postdoctoral fellowship in neurobiology at Caltech (1999). From 1999 to 2011, Dr Morrison was at the University of Michigan where he Directed their Center for Stem Cell Biology. Recently, Dr Morrison moved to the University of Texas Southwestern Medical Center where he is the founding Director of the new Children’s Research Institute. Dr Morrison’s laboratory studies the mechanisms that regulate stem cell self-renewal and stem cell aging, as well as the role these mechanisms play in cancer. Dr Morrison was a Searle Scholar (2000–2003), was named in Technology Review Magazine’s list of 100 young innovators (2002), received the Presidential Early Career Award for Scientists and Engineers (2003), the International Society for Hematology and Stem Cell’s McCulloch and Till Award (2007), the American Association of Anatomists Harland Mossman Award (2008), and a MERIT Award from the National Institute on Aging. Dr Morrison has also been active in public policy issues surrounding stem cells. For example, he has twice testified before Congress and was a leader in the successful “Proposal 2” campaign to protect stem cell research in Michigan’s state constitution.

    Expertise
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Research focus
    cancer biology
    tissue stem cells
    hematopoietic system
    blood
    Competing interests statement
    Sean Morrison receives funding from the Howard Hughes Medical Institute, the National Institutes of Health, and the Cancer Prevention and Research Institute of Texas. In addition to being a Senior editor for eLife, he is a member of the editorial boards of Cell Stem Cell, the Journal of Experimental Medicine, the EMBO Journal, the Faculty of 1000, Current Opinion in Cell Biology, Cancer Cell, EMBO Reports, and Stem Cell Reports. He serves on the scientific advisory boards of the California Institute for Regenerative Medicine, the University of Washington Institute for Stem Cells and Regenerative Medicine, the University of California, Los Angeles Broad Stem Cell Research Center, and the Common Fund for the National Institutes of Health Center for Regenerative Medicine. He is President-Elect of the International Society for Stem Cell Research. He is a co-founder and shareholder in OncoMed Pharmaceuticals, a consultant and shareholder in G1 Therapeutics, a shareholder in Fate Therapeutics, and a consultant for Molecular Devices.
  3. Jeffrey Settleman

    Calico Life Sciences, United States

    Jeff Settleman is the Head of Oncology Research at Calico Life Sciences, an aging-focused biotechnology company in South San Francisco. His research is focused on cancer cell biology and therapeutics. He is particularly interested in mechanisms of drug resistance and the phenotypic heterogeneity within cell populations that drives tumor evolution. He received a Ph.D. degree in Genetics from Yale University in 1989, conducting thesis research under the mentorship of Dr. Dan Dimaio, and from 1989-1992 was a postdoctoral fellow at the Whitehead Institute for Biomedical Research at M.I.T. in Dr. Robert Weinberg’s laboratory. He joined the Harvard School of Medicine faculty in 1992, and was named the Laurel Schwartz Professor of Oncology at Harvard Medical School in 2008. He was also the Director of the Center for Molecular Therapeutics, the Scientific Director of the Massachusetts General Hospital Cancer Center, and the Leader of the Cancer Cell Biology program within the Dana Farber/Harvard Cancer Center. In 2010, Dr. Settleman transitioned from academia to industry, joining Genentech as the Senior Director of Discovery Oncology, where he oversaw efforts to identify and validate targets for oncology drug discovery and to discover predictive biomarkers for new cancer therapies.

    Expertise
    Cancer Biology
    Research focus
    cancer cell biology
    signal transduction
    tumor heterogeneity
    signaling
    epigenetics
  4. Maarten van Lohuizen

    The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Netherlands

    Maarten van Lohuizen received his PhD at the NKI/University of Amsterdam in 1992 studying cooperating oncogenes with Anton Berns. After a postoc at the University of California, San Francisco, he started his lab at the NKI in 1995 and heads the Division of Molecular Genetics. He also is a professor at the University of Amsterdam Medical Center, department Clinical Genetics & Oncogenomics, focusing on epigenetics and stem cells. Maarten studies epigenetic master switches that control cell and tissue development, and how these go awry in cancer. Specifically, his group focuses on the mechanism of stable inherited transcriptional repression by Polycomb group proteins and the effects of deregulation of Polycomb genes on development, cell cycle control, cancer formation and stem cell maintenance. Current focus is on Glioblastoma, non-small cell lung cancer and mesothelioma, using state of the art mouse models and genetic screening and drug screening to find new effective epigenetic drug combinations to target these cancers. Maarten was elected as European Molecular Biology Organization (EMBO) member (2004); Member of Academia Europaea (2015) and Member of the Oncode Institute (2017).

    Expertise
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Research focus
    epigenetics
    cancer biology
    stem cells
    chromatin
    Polycomb group proteins
    Competing interests statement
    Maarten van Lohuizen receives funding from The Dutch Cancer Society (KWF), the Netherlands Organization of Scientific research (NWO), The Gravity program, Cancer Genomics Centre Netherlands (CGC.nl), the European Research Council and the Oncode Institute. He is editorial board member of Current Opinion in Genetics & Development, Epigenetics & Chromatin, Stem Cell reports and the Faculty of 1000.

Reviewing editors

  1. Utpal Banerjee

    University of California, Los Angeles, United States

    Expertise
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Human Biology and Medicine
    Developmental Biology
    Research focus
    haematopoiesis
    cancer biology
    Experimental organism
    Drosophila
  2. Xuetao Cao

    Zhejiang University School of Medicine, China

    Expertise
    Cancer Biology
    Immunology and Inflammation
    Research focus
    immunology of APCs
    TLR signalling and immune regulation
    cancer immunotherapy and gene therapy
  3. Irwin Davidson

    Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS/INSERM/UDS, France

    Expertise
    Biochemistry and Chemical Biology
    Cancer Biology
    Chromosomes and Gene Expression
    Research focus
    transcription
    chromatin
    genomics
    cancer
    Experimental organism
    human
    mouse
  4. Ralph J DeBerardinis

    University of Texas Southwestern Medical Center, United States

    Expertise
    Cancer Biology
    Cell Biology
    Human Biology and Medicine
    Research focus
    cancer
    metabolism
    metabolic pathways
    medicine
    genetics
    Experimental organism
    human
    mouse
  5. Elisabetta Dejana

    FIRC Institute of Molecular Oncology, Italy

    Expertise
    Cancer Biology
    Cell Biology
    Developmental Biology
    Research focus
    angiogenesis
    cell adhesion
    VE-cadherin
    vascular permeability
    vascular development and patterning
    endothelium
    blood brain barrier
    Experimental organism
    mouse
  6. Martin Eilers

    University of Würzburg, Germany

    Expertise
    Cancer Biology
    Research focus
    Myc proteins
    Myc function
    Targeting N-MYC/AURORA for tumor therapy
    Myc and Ubiquitin
    Experimental organism
    human
  7. Joaquin Espinosa

    University of Colorado Anschutz Medical Campus, United States

    Expertise
    Cancer Biology
    Cell Biology
    Human Biology and Medicine
    Research focus
    cancer biology
    apoptosis
    p53
    tumor suppressors
    trisomy 21
    Down syndrome
    gene expression
    chromatin
  8. Margaret Frame

    University of Edinburgh, United Kingdom

    Expertise
    Cancer Biology
    Research focus
    cancer
    cell adhesion networks
    nodal tyrosine kinases
  9. Michael R Green

    University of Massachusetts Medical School, United States

    Expertise
    Cancer Biology
    Chromosomes and Gene Expression
    Human Biology and Medicine
    Research focus
    transcription
    pre-mRNA splicing
    cancer molecular biology
    oncology
    genetics
    functional genomics
    Experimental organism
    human
    mouse
    S. cerevisiae
  10. Matthew G. Vander Heiden

    Massachusetts Institute of Technology, United States

    Expertise
    Cancer Biology
    Human Biology and Medicine
    Research focus
    cancer metabolism
    cell metabolism
    metabolic biochemistry
    Experimental organism
    mouse
  11. Tony Hunter

    Salk Institute for Biological Studies, United States

    Expertise
    Cancer Biology
    Cell Biology
    Research focus
    cell signaling and basic cancer biology
    signaling pathways in animal and human cells
    cell cycle
    phosphorylation
    protein modification
    cancer
  12. Gou Young Koh

    Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST), South Korea

    Expertise
    Cancer Biology
    Human Biology and Medicine
    Developmental Biology
    Research focus
    angiogenesis
    lymphangiogenesis
    adipogenesis
    cardiogenesis
    vascular and cardiovascular biology
  13. Ross Levine

    Memorial Sloan Kettering Cancer Center, United States

    Expertise
    Cancer Biology
    Research focus
    genetic basis of blood disorders
    myeloid malignancies
    myeloproliferative neoplasms
    leukemia
    Experimental organism
    human
  14. Beate Lichtenberger

    Medical University of Vienna, Austria

    Expertise
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Research focus
    Cancer-associated fibroblasts (CAFs)
    fibroblast-mediated skin pathologies
    skin cancer
    stem cell fate decisions
    Experimental organism
    human
    mouse
  15. Ravindra Majeti

    Stanford University, United States

    Expertise
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Research focus
    hematopoietic stem cell function
    leukemia
    Experimental organism
    human
  16. Joan Massagué

    Memorial Sloan Kettering Cancer Center, United States

    Expertise
    Cancer Biology
    Cell Biology
    Human Biology and Medicine
    Research focus
    cell signalling
    cell fate
    tumor heterogeneity
    metastasis
    Experimental organism
    human tissue
    mouse
  17. Martin McMahon

    University of Utah, United States

    Expertise
    Cancer Biology
    Research focus
    metastatic melanoma
    lung cancer
    thyroid cancer
    Experimental organism
    mouse
    human
  18. Maureen Murphy

    The Wistar Institute, United States

    Expertise
    Cancer Biology
    Research focus
    p53
    genetics
    ferroptosis
    cell death
    melanoma
    heat shock proteins
  19. Paivi Ojala

    University of Helsinki, Finland

    Expertise
    Cancer Biology
    Research focus
    cancer biology
    tumor microenvironment
    virus-host cell interactions
    virus-induced oncogenesis
    Experimental organism
    human
  20. Duojia Pan

    UT Southwestern Medical Center, United States

    Expertise
    Cancer Biology
    Cell Biology
    Human Biology and Medicine
    Research focus
    signal transduction
    growth control
    cancer biology
    Experimental organism
    Drosophila
  21. Jody Rosenblatt

    University of Utah, United States

    Expertise
    Cell Biology
    Human Biology and Medicine
    Cancer Biology
    Research focus
    apoptosis
    mitosis
    cell extrusion
    epithelial
    homeostasis
    morphogenesis
    cancer cell biology
  22. Charles Sawyers

    Memorial Sloan-Kettering Cancer Center, United States

    Expertise
    Cancer Biology
    Human Biology and Medicine
    Research focus
    oncology and translational medicine
    oncology
    translational medicine
    Experimental organism
    human
  23. Nima Sharifi

    Cleveland Clinic, United States

    Expertise
    Biochemistry and Chemical Biology
    Cancer Biology
    Research focus
    prostate cancer
    androgens
    steroid metabolism
    hormonal therapy
    androgen receptor
    Experimental organism
    human
  24. Xiaobing Shi

    Van Andel Institute, United States

    Expertise
    Chromosomes and Gene Expression
    Cancer Biology
    Research focus
    cancer epigenetics
    chromatin
    post-translational modifications of histones
    gene expression
  25. Alfonso Valencia

    Barcelona Supercomputing Center, Spain

    Expertise
    Cancer Biology
    Computational and Systems Biology
    Research focus
    bioinformatics
    computational biology
    structural bioinformatics
    co-evolution
    cancer genomics
    text mining
  26. Richard M White

    Memorial Sloan Kettering Cancer Center, United States

    Expertise
    Cancer Biology
    Developmental Biology
    Stem Cells and Regenerative Medicine
    Research focus
    cancer
    metastasis
    genetics
    melanocyte
    melanoma
    neural crest
    Experimental organism
    human
    zebrafish
  27. Wilbert Zwart

    Netherlands Cancer Institute, Netherlands

    Expertise
    Cancer Biology
    Human Biology and Medicine
    Research focus
    breast cancer
    prostate cancer
    hormonal regulation
    epigenetics
    transcription factors
    genomic profiling
    Experimental organism
    human